Skip to main content

Nasacort Side Effects

Generic name: triamcinolone nasal

Medically reviewed by Drugs.com. Last updated on Dec 3, 2023.

Note: This document contains side effect information about triamcinolone nasal. Some dosage forms listed on this page may not apply to the brand name Nasacort.

Applies to triamcinolone nasal: nasal spray.

Serious side effects of Nasacort

Along with its needed effects, triamcinolone nasal (the active ingredient contained in Nasacort) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking triamcinolone nasal:

More common

Less common

Incidence not known

Other side effects of Nasacort

Some side effects of triamcinolone nasal may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Less common

Incidence not known

For Healthcare Professionals

Applies to triamcinolone nasal: nasal aerosol, nasal aerosol with adapter, nasal spray.

Nervous system

Common (1% to 10%): Headache

Frequency not reported: Dizziness, alteration of taste and smell[Ref]

Respiratory

Common (1% to 10%): Epistaxis, cough

Rare (less than 0.1%): Nasal septum perforations

Frequency not reported: Nasal irritation, dry mucous membrane, nasal congestion, sneezing, dyspnea[Ref]

Immunologic

Common (1% to 10%): Flu syndrome, pharyngitis, rhinitis, bronchitis

Gastrointestinal

Common (1% to 10%): Dyspepsia, tooth disorder

Frequency not reported: Nausea

Ocular

Frequency not reported: Chorioretinopathy, cataract, glaucoma, increased ocular pressure, blurred vision[Ref]

Hypersensitivity

Frequency not reported: Hypersensitivity (including rash, urticaria, pruritus, facial edema)

Musculoskeletal

Postmarketing reports: Reduction of growth velocity in children

Psychiatric

Frequency not reported: Insomnia

Other

Frequency not reported: Fatigue, decreased blood cortisol

Frequently asked questions

References

1. Intranasal triamcinolone for allergic rhinitis. Med Lett Drugs Ther. 1991;33:116-7.

2. Settipane G, Korenblat PE, Winder J, Lumry W, Murphree J, Alderfer VB, Simpson B, Smith JA. Triamcinolone acetonide aqueous nasal spray in patients with seasonal ragweed allergic rhinitis: a placebo-controlled, double-blind study. Clin Ther. 1995;17:252-63.

3. Kobayashi RH, Beaucher WN, Koepke JW, Luskin A, Ransom JH, Rosen JP, Sullivan MJ, Alderfer VB, Simpson B, Smith JA. Triamcinolone acetonide aqueous nasal spray for the treatment of patients with perennial allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled study. Clin Ther. 1995;17:503-13.

4. Bernstein DI, Creticos PS, Busse WW, Cohen R, Graft DF, Howland WC, Lumry WR, Pedinoff AJ, Ratner PH, Lim J, Stokes A, M. Comparison of triamcinolone acetonide nasal inhaler with astemizole in the treatment of ragweed-induced allergic rhinitis. J Allergy Clin Immunol. 1996;97:749-55.

5. Banov CH, Silvers WS, Green AV, Vanbavel JH, Winder JA, Feiss G, Simpson B, Furst JA, Smith JA. Placebo-controlled, double-blind study of the efficacy and safety of triamcinolone acetonide aerosol nasal inhaler in pediatric patients with seasonal allergic rhinitis. Clin Ther. 1996;18:265-72.

6. Howland WC, Dockhorn R, Gillman S, Gross GN, Hille D, Simpson B, Furst JA, Feiss G, Smith JA. A comparison of effects of triamcinolone acetonide aqueous nasal spray, oral prednisone, and placebo on adrenocortical function in male patients with allergic rhinitis. J Allergy Clin Immunol. 1996;98:32-8.

7. Munk ZM, Laforce C, Furst JA, Simpson B, Feiss G, Smith JA. Efficacy and safety of triamcinolone acetonide aqueous nasal spray in patients with seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 1996;77:277-81.

8. Product Information. Nasacort (triamcinolone nasal). Rhone Poulenc Rorer. 2001;PROD.

9. Spaeth GL, Rodrigues MM, Weinreb S. Steroid-induced glaucoma: A. Persistent elevation of intraocular pressure B. Histopathological aspects. Trans Am Ophthalmol Soc. 1977;75:353-81.

10. Cumming RG, Mitchell P, Leeder SR. Use of inhaled corticosteroids and the risk of cataracts. N Engl J Med. 1997;337:8-14.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.